Longship, a private equity investor dedicated to the Norwegian lower mid-market, has held the first and final close of its fourth fund at NOK2.4bn (US$250m) hard cap, reached after just 11 weeks.
The fund was significantly oversubscribed, securing support from existing investors alongside new commitments from a group of institutional...
LSEG-listed Bridgepoint, a leading mid-market investor, has agreed to acquire Obagi Medical, the dermatological skincare and aesthetics business of Nasdaq-listed Waldencast, in a transaction valued at up to US$460m.
“Obagi Medical is a category-leading brand . . . in physician-dispensed skincare – one of the fastest growing segments of the dermatology and aesthetics market,” said Fabrice Turcq, head of healthcare and partner at Bridgepoint.
Founded in 1988, Obagi Medical is a pioneer in medical-grade skincare. Its product range includes both prescription and non-prescription items addressing premature aging, photodamage, skin discoloration, acne, and...